DK28893D0 - Benzimidazole derivater, deres fremstilling og anvendelse - Google Patents

Benzimidazole derivater, deres fremstilling og anvendelse

Info

Publication number
DK28893D0
DK28893D0 DK93288A DK28893A DK28893D0 DK 28893 D0 DK28893 D0 DK 28893D0 DK 93288 A DK93288 A DK 93288A DK 28893 A DK28893 A DK 28893A DK 28893 D0 DK28893 D0 DK 28893D0
Authority
DK
Denmark
Prior art keywords
preparation
benzimidazole derivatives
hydrogen
human
compound
Prior art date
Application number
DK93288A
Other languages
Danish (da)
English (en)
Inventor
Soeren-Peter Olesen
Leif Helth Jensen
Peter Moldt
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Priority to DK93288A priority Critical patent/DK28893D0/da
Publication of DK28893D0 publication Critical patent/DK28893D0/da
Priority to AU56492/94A priority patent/AU679023B2/en
Priority to US08/206,506 priority patent/US5475015A/en
Priority to NZ260049A priority patent/NZ260049A/en
Priority to EP94610013A priority patent/EP0617023B1/en
Priority to ES94610013T priority patent/ES2123741T3/es
Priority to DK94610013T priority patent/DK0617023T3/da
Priority to DE69414017T priority patent/DE69414017T2/de
Priority to AT94610013T priority patent/ATE172453T1/de
Priority to CA002118997A priority patent/CA2118997C/en
Priority to JP04275094A priority patent/JP3748901B2/ja
Priority to KR1019940004982A priority patent/KR100300800B1/ko
Priority to NO940908A priority patent/NO304518B1/no
Priority to ZA941816A priority patent/ZA941816B/xx
Priority to FI941214A priority patent/FI941214A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK93288A 1993-03-15 1993-03-15 Benzimidazole derivater, deres fremstilling og anvendelse DK28893D0 (da)

Priority Applications (15)

Application Number Priority Date Filing Date Title
DK93288A DK28893D0 (da) 1993-03-15 1993-03-15 Benzimidazole derivater, deres fremstilling og anvendelse
AU56492/94A AU679023B2 (en) 1993-03-15 1994-03-02 Benzimidazole derivatives, their preparation and use
US08/206,506 US5475015A (en) 1993-03-15 1994-03-04 Benzimidazole derivatives, their preparation and pharmaceutical use
NZ260049A NZ260049A (en) 1993-03-15 1994-03-08 Benzimidazole derivatives preparation and pharmaceutical compositions thereof
AT94610013T ATE172453T1 (de) 1993-03-15 1994-03-11 Benzimidazolderivate, ihre herstellung und verwendung
DK94610013T DK0617023T3 (da) 1993-03-15 1994-03-11 Benzimidazolderivater, deres fremstilling og anvendelse
ES94610013T ES2123741T3 (es) 1993-03-15 1994-03-11 Derivados de bencimidazol, su preparacion y uso.
EP94610013A EP0617023B1 (en) 1993-03-15 1994-03-11 Benzimidazole derivatives, their preparation and use
DE69414017T DE69414017T2 (de) 1993-03-15 1994-03-11 Benzimidazolderivate, ihre Herstellung und Verwendung
CA002118997A CA2118997C (en) 1993-03-15 1994-03-14 Benzimidazole derivatives, their preparation and use
JP04275094A JP3748901B2 (ja) 1993-03-15 1994-03-14 ベンズイミダゾール誘導体、その製造方法及びその使用方法
KR1019940004982A KR100300800B1 (ko) 1993-03-15 1994-03-14 벤즈이미다졸유도체,이의제조방법및이를포함하는약제학적조성물_
NO940908A NO304518B1 (no) 1993-03-15 1994-03-14 Benzimidazoler, anvendelse derav for fremstilling av et medikament, samt farmas°ytiske preparater som omfatter dem
ZA941816A ZA941816B (en) 1993-03-15 1994-03-15 Benzimidazole derivatives their preparation and use
FI941214A FI941214A (fi) 1993-03-15 1994-03-15 Bentsimidatsolin johdannaisia, niiden valmistus ja käyttö

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93288A DK28893D0 (da) 1993-03-15 1993-03-15 Benzimidazole derivater, deres fremstilling og anvendelse

Publications (1)

Publication Number Publication Date
DK28893D0 true DK28893D0 (da) 1993-03-15

Family

ID=8091872

Family Applications (2)

Application Number Title Priority Date Filing Date
DK93288A DK28893D0 (da) 1993-03-15 1993-03-15 Benzimidazole derivater, deres fremstilling og anvendelse
DK94610013T DK0617023T3 (da) 1993-03-15 1994-03-11 Benzimidazolderivater, deres fremstilling og anvendelse

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK94610013T DK0617023T3 (da) 1993-03-15 1994-03-11 Benzimidazolderivater, deres fremstilling og anvendelse

Country Status (14)

Country Link
US (1) US5475015A (fi)
EP (1) EP0617023B1 (fi)
JP (1) JP3748901B2 (fi)
KR (1) KR100300800B1 (fi)
AT (1) ATE172453T1 (fi)
AU (1) AU679023B2 (fi)
CA (1) CA2118997C (fi)
DE (1) DE69414017T2 (fi)
DK (2) DK28893D0 (fi)
ES (1) ES2123741T3 (fi)
FI (1) FI941214A (fi)
NO (1) NO304518B1 (fi)
NZ (1) NZ260049A (fi)
ZA (1) ZA941816B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW467902B (en) * 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators
EP1198456B1 (en) * 1999-08-03 2007-09-19 Abbott Laboratories Potassium channel openers
DE10209520A1 (de) * 2002-03-04 2003-09-25 4Sc Ag Neue Modulatoren von Kaliumkanälen
JP2005533814A (ja) * 2002-06-26 2005-11-10 ポセイドン・ファーマスーティカルス・アクティーゼルスカブ 新規ベンズイミダゾール−２−オン誘導体及びその使用方法
WO2005035498A1 (ja) * 2003-10-08 2005-04-21 Dainippon Sumitomo Pharma Co., Ltd. 含窒素二環性化合物の摂食調節剤としての用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ239540A (en) * 1990-09-24 1993-11-25 Neurosearch As 1-phenyl benzimidazole derivatives and medicaments
US5200422A (en) * 1990-09-24 1993-04-06 Neurosearch A/S Benzimidazole derivatives, their preparation and use

Also Published As

Publication number Publication date
KR100300800B1 (ko) 2001-11-22
DK0617023T3 (da) 1999-06-28
AU5649294A (en) 1994-09-22
CA2118997C (en) 2002-05-28
JPH06321910A (ja) 1994-11-22
NO940908D0 (no) 1994-03-14
US5475015A (en) 1995-12-12
JP3748901B2 (ja) 2006-02-22
NO304518B1 (no) 1999-01-04
FI941214A0 (fi) 1994-03-15
EP0617023A1 (en) 1994-09-28
NO940908L (no) 1994-09-16
ATE172453T1 (de) 1998-11-15
CA2118997A1 (en) 1994-09-16
ZA941816B (en) 1995-10-13
DE69414017T2 (de) 1999-04-08
DE69414017D1 (de) 1998-11-26
FI941214A (fi) 1994-09-16
NZ260049A (en) 1996-03-26
KR940021534A (ko) 1994-10-19
EP0617023B1 (en) 1998-10-21
AU679023B2 (en) 1997-06-19
ES2123741T3 (es) 1999-01-16

Similar Documents

Publication Publication Date Title
DK1137762T3 (da) Behandling af Pompes sygdom
ES2166381T3 (es) Tratamiento de enfermedades vasculares hiperproliferativas.
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
HU9600834D0 (en) Quinazoline derivatives
SE9604786D0 (sv) New compounds
PT950057E (pt) Enantiomeros de 3-piridilo e sua utilizacao como analgesicos
DE69928226T8 (de) Chemokin rezeptor antagonisten und verwendung
DK0477819T3 (da) Benzimidazolderivater, fremstilling og anvendelse heraf
DE4394931T1 (de) Verwendung von Norastemizol zur Behandlung von allergischen Erkrankungen
DK0617023T3 (da) Benzimidazolderivater, deres fremstilling og anvendelse
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
DK0617959T3 (da) Lægemiddel til behandling af hudsygdomme
NO902157D0 (no) Butensyrederivater for terapeutisk anvendelse.
IT1223395B (it) Composti ad attivita' cardiovascolare
EP2266566A3 (en) Nicotinamide derivatives and their use as therapeutic agents
DE3884878D1 (de) Uricosuretische Zusammensetzung.
DE69116187D1 (de) Verwendung eines Dihydropyridins zur Verbesserung der Blutzirkulation des inneren Ohres
DE68918240D1 (de) 1,4-Dihydropyridin-Derivate.
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
A0 Application filed
AHS Application shelved for other reasons than non-payment